Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

355 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 355 results

Large-scale testing (Phase 3)Study completedNCT06088043
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Who this might be right for
Plaque Psoriasis
Takeda 693
Early research (Phase 1)Study completedNCT07051538
What this trial is testing

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 64
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Large-scale testing (Phase 3)Study completedNCT04967508
What this trial is testing

Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisModerate to Severe Plaque Psoriasis
Samsung Bioepis Co., Ltd. 503
Large-scale testing (Phase 3)Study completedNCT01782924
What this trial is testing

Clinical Study of KHK4827

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 145
Testing effectiveness (Phase 2)Study completedNCT01710046
What this trial is testing

Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT01194219
What this trial is testing

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 844
Large-scale testing (Phase 3)Study completedNCT05120297
What this trial is testing

Efficacy and Safety of AK101 in Subjects With Psoriasis

Who this might be right for
Psoriasis Vulgaris
Akeso 452
Post-approval studies (Phase 4)Study completedNCT01893567
What this trial is testing

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Who this might be right for
Plaque Psoriasis
Galderma R&D 28
Post-approval studies (Phase 4)Study completedNCT00493324
What this trial is testing

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 43
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Post-approval studies (Phase 4)Ended earlyNCT00953329
What this trial is testing

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

Who this might be right for
Chronic Plaque Psoriasis
John Murray 1
Large-scale testing (Phase 3)Study completedNCT03721172
What this trial is testing

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Who this might be right for
Psoriasis
Amgen 595
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Large-scale testing (Phase 3)Study completedNCT01406938
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 967
Not applicableLooking for participantsNCT05994976
What this trial is testing

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Who this might be right for
AcneAtopic DermatitisChronic Hand Eczema+3 more
Innovaderm Research Inc. 500
Large-scale testing (Phase 3)Study completedNCT05509361
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 950
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Next Page